This book is based on detailed coverage of the role of phytochemicals as a epigenetic modifier to prevent various cancers. It presents the novel features of phytochemicals and their role in preventing cancer by regulating DNA, RNA and protein levels. It also covers the role of various kinds of phytochemicals especially focused on vitamins, flavconoids, polyphenois and phytols in cancer prevention and treatment. It also deals with the discovery of novel biomarkers for cancer treatment that are enabled by phytochemical modulation of epigenetic activity, highlighting its promise as an alternative treatment approach in cancer. The major goal of this project is to summarise what we currently know about natural product active chemicals, including their pharmacologic activity and molecular markers. There are several books available on phytochemicals and cancer, but to date there is no such book reported which compiles the broad spectrum of applications of phytochemicals at epigenetic levels. This project is themed to combine, promote and lift the potentialities of dietary phytochemicals in cancer prevention and treatment and reduce the dependability on synthetic drugs which often cause many negative side effects.

Key Features: * Details the role of various kinds of phytochemicals in cancer chemoprevention by specific targeting at the epigenetic level.

This book includes the most up-to-date point-of-care cancer detection technologies and processes, which are based on biomedical sensors, microfluidics, and integrated systems engineering. This book is an ideal resource for researchers in the fields of nanotechnology, nanobiotechnology, and medical studies.

This book aims to discuss the various drug delivery approaches of neuroprotective medicines via nanoparticles, such as enzymes, monoclonal antibodies, neurotrophic factors, pharmaceutical drugs, and nucleic acid-based medication, to manage Alzheimer''s disease.

Nanomedicine in the Treatment and Management of Alzheimer''s Disease investigates drug administration approaches, either separately or in combination, to improve neuroprotection in Alzheimer''s disease. The book examines various novel therapeutic applications of nanomaterials in drug delivery for the central nervous system in Alzheimer''s disease treatment. The book explores the role of nanoparticles in crossing the blood–brain barrier and blood-CSF barrier in the treatment and management of Alzheimer''s disease. The authors also explain the nanoparticle-based delivery of therapeutic molecules including phytochemicals, peptides, siRNA, enzymes, and monoclonal antibodies in the treatment of Alzheimer''s disease. Finally, the book also discusses the various challenges and future perspectives of nanomedicine in the management of Alzheimer’s disease.

The book will help in bridging the gap of knowledge in neurosciences, neurotherapeutics, nanotechnology, and nanomedicine domains. The book chapter may be useful to educators, researchers, legislators, and medical professionals including pharmacologists, biochemists, corporate pharma R&D researchers, neurologists, and scientists involved in neurodegenerative diseases and nanomedicine.

This book aims to discuss the various drug delivery approaches of neuroprotective medicines via nanoparticles, such as enzymes, monoclonal antibodies, neurotrophic factors, pharmaceutical drugs, and nucleic acid-based medication, to manage Alzheimer''s disease.

Nanomedicine in the Treatment and Management of Alzheimer''s Disease investigates drug administration approaches, either separately or in combination, to improve neuroprotection in Alzheimer''s disease. The book examines various novel therapeutic applications of nanomaterials in drug delivery for the central nervous system in Alzheimer''s disease treatment. The book explores the role of nanoparticles in crossing the blood–brain barrier and blood-CSF barrier in the treatment and management of Alzheimer''s disease. The authors also explain the nanoparticle-based delivery of therapeutic molecules including phytochemicals, peptides, siRNA, enzymes, and monoclonal antibodies in the treatment of Alzheimer''s disease. Finally, the book also discusses the various challenges and future perspectives of nanomedicine in the management of Alzheimer’s disease.

The book will help in bridging the gap of knowledge in neurosciences, neurotherapeutics, nanotechnology, and nanomedicine domains. The book chapter may be useful to educators, researchers, legislators, and medical professionals including pharmacologists, biochemists, corporate pharma R&D researchers, neurologists, and scientists involved in neurodegenerative diseases and nanomedicine.

This book covers various cancer chemotherapeutics, offering research-oriented overviews of phytochemical-based cancer treatments. It contrasts nano-formulated phytochemical delivery with conventional chemotherapy, introducing nanocarriers or bioengineering for poly-chemotherapy and phytochemicals as alternative treatments to reduce resistance. The text elaborates on the nano-formulation techniques and synthesis approaches of phytochemicals as drugs, the targeted drug delivery facilitated by nanocarriers, and subsequent mechanisms of drug release. Additionally, it examines the implications of nano-formulated phytochemicals in cancer therapeutics and their impact on cancer treatment and prevention. By enhancing bioavailability and improving functional qualities through nanoencapsulation, this innovative approach promises significant advancements in cancer therapy. Key concepts include dietary phytochemicals'' role in various types of cancer chemotherapeutics, the pharmacological mechanisms of action in prevention and treatment, and strategies to enhance chemotherapy and radiotherapy efficacy. The book also presents preclinical and clinical studies on the efficacy of phytochemicals in cancer treatment. Additionally, it highlights improvements in drug delivery systems using nanotechnology-based dosage forms for herbal drugs. The content is designed for professionals involved in drug development, including chemists, pharmacists, biologists, biotechnologists, industrialists, nanotechnologists, microbiologists,  economists, and all disciplines related to cancer treatment and phytochemical-based drug development. Academic students, scientists, and researchers at universities, institutes, hospitals, botanical institutes, pharmaceutical industries, government organizations, and NGOs will find invaluable insights into the application of phytochemical drugs in cancer treatment. By providing a detailed examination of cutting-edge research on nano-formulated phytochemicals for cancer therapy, this book invites readers to rethink traditional approaches to chemotherapy and explore innovative solutions that promise better outcomes for patients worldwide.

This book is based on detailed coverage of the role of phytochemicals as a epigenetic modifier to prevent various cancers. It presents the novel features of phytochemicals and their role in preventing cancer by regulating DNA, RNA and protein levels. It also covers the role of various kinds of phytochemicals especially focused on vitamins, flavconoids, polyphenois and phytols in cancer prevention and treatment. It also deals with the discovery of novel biomarkers for cancer treatment that are enabled by phytochemical modulation of epigenetic activity, highlighting its promise as an alternative treatment approach in cancer. The major goal of this project is to summarise what we currently know about natural product active chemicals, including their pharmacologic activity and molecular markers. There are several books available on phytochemicals and cancer, but to date there is no such book reported which compiles the broad spectrum of applications of phytochemicals at epigenetic levels. This project is themed to combine, promote and lift the potentialities of dietary phytochemicals in cancer prevention and treatment and reduce the dependability on synthetic drugs which often cause many negative side effects.

Key Features: * Details the role of various kinds of phytochemicals in cancer chemoprevention by specific targeting at the epigenetic level.

This book includes the most up-to-date point-of-care cancer detection technologies and processes, which are based on biomedical sensors, microfluidics, and integrated systems engineering. This book is an ideal resource for researchers in the fields of nanotechnology, nanobiotechnology, and medical studies.

This book aims to discuss the various drug delivery approaches of neuroprotective medicines via nanoparticles, such as enzymes, monoclonal antibodies, neurotrophic factors, pharmaceutical drugs, and nucleic acid-based medication, to manage Alzheimer''s disease.

Nanomedicine in the Treatment and Management of Alzheimer''s Disease investigates drug administration approaches, either separately or in combination, to improve neuroprotection in Alzheimer''s disease. The book examines various novel therapeutic applications of nanomaterials in drug delivery for the central nervous system in Alzheimer''s disease treatment. The book explores the role of nanoparticles in crossing the blood–brain barrier and blood-CSF barrier in the treatment and management of Alzheimer''s disease. The authors also explain the nanoparticle-based delivery of therapeutic molecules including phytochemicals, peptides, siRNA, enzymes, and monoclonal antibodies in the treatment of Alzheimer''s disease. Finally, the book also discusses the various challenges and future perspectives of nanomedicine in the management of Alzheimer’s disease.

The book will help in bridging the gap of knowledge in neurosciences, neurotherapeutics, nanotechnology, and nanomedicine domains. The book chapter may be useful to educators, researchers, legislators, and medical professionals including pharmacologists, biochemists, corporate pharma R&D researchers, neurologists, and scientists involved in neurodegenerative diseases and nanomedicine.

This book aims to discuss the various drug delivery approaches of neuroprotective medicines via nanoparticles, such as enzymes, monoclonal antibodies, neurotrophic factors, pharmaceutical drugs, and nucleic acid-based medication, to manage Alzheimer''s disease.

Nanomedicine in the Treatment and Management of Alzheimer''s Disease investigates drug administration approaches, either separately or in combination, to improve neuroprotection in Alzheimer''s disease. The book examines various novel therapeutic applications of nanomaterials in drug delivery for the central nervous system in Alzheimer''s disease treatment. The book explores the role of nanoparticles in crossing the blood–brain barrier and blood-CSF barrier in the treatment and management of Alzheimer''s disease. The authors also explain the nanoparticle-based delivery of therapeutic molecules including phytochemicals, peptides, siRNA, enzymes, and monoclonal antibodies in the treatment of Alzheimer''s disease. Finally, the book also discusses the various challenges and future perspectives of nanomedicine in the management of Alzheimer’s disease.

The book will help in bridging the gap of knowledge in neurosciences, neurotherapeutics, nanotechnology, and nanomedicine domains. The book chapter may be useful to educators, researchers, legislators, and medical professionals including pharmacologists, biochemists, corporate pharma R&D researchers, neurologists, and scientists involved in neurodegenerative diseases and nanomedicine.

This book covers various cancer chemotherapeutics, offering research-oriented overviews of phytochemical-based cancer treatments. It contrasts nano-formulated phytochemical delivery with conventional chemotherapy, introducing nanocarriers or bioengineering for poly-chemotherapy and phytochemicals as alternative treatments to reduce resistance. The text elaborates on the nano-formulation techniques and synthesis approaches of phytochemicals as drugs, the targeted drug delivery facilitated by nanocarriers, and subsequent mechanisms of drug release. Additionally, it examines the implications of nano-formulated phytochemicals in cancer therapeutics and their impact on cancer treatment and prevention. By enhancing bioavailability and improving functional qualities through nanoencapsulation, this innovative approach promises significant advancements in cancer therapy. Key concepts include dietary phytochemicals'' role in various types of cancer chemotherapeutics, the pharmacological mechanisms of action in prevention and treatment, and strategies to enhance chemotherapy and radiotherapy efficacy. The book also presents preclinical and clinical studies on the efficacy of phytochemicals in cancer treatment. Additionally, it highlights improvements in drug delivery systems using nanotechnology-based dosage forms for herbal drugs. The content is designed for professionals involved in drug development, including chemists, pharmacists, biologists, biotechnologists, industrialists, nanotechnologists, microbiologists,  economists, and all disciplines related to cancer treatment and phytochemical-based drug development. Academic students, scientists, and researchers at universities, institutes, hospitals, botanical institutes, pharmaceutical industries, government organizations, and NGOs will find invaluable insights into the application of phytochemical drugs in cancer treatment. By providing a detailed examination of cutting-edge research on nano-formulated phytochemicals for cancer therapy, this book invites readers to rethink traditional approaches to chemotherapy and explore innovative solutions that promise better outcomes for patients worldwide.